Provided by Tiger Trade Technology Pte. Ltd.

Bicycle Therapeutics Limited

4.33
-0.0400-0.92%
Volume:34.70K
Turnover:149.71K
Market Cap:302.28M
PE:-1.58
High:4.34
Open:4.33
Low:4.28
Close:4.37
52wk High:9.16
52wk Low:3.75
Shares:69.81M
Float Shares:3.08M
Volume Ratio:0.59
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7382
EPS(LYR):-3.1605
ROE:-32.30%
ROA:-17.91%
PB:0.59
PE(LYR):-1.37

Loading ...

Bicycle Therapeutics posts corporate presentation outlining Bicycle molecule platform and oncology pipeline

Reuters
·
Jun 01

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
May 22

Bicycle Therapeutics reports initial Duravelo-2 Phase 2 data in metastatic urothelial cancer

Reuters
·
May 22

Morgan Stanley Sticks to Its Hold Rating for Bicycle Therapeutics (BCYC)

TIPRANKS
·
May 18

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week

MT Newswires Live
·
May 01

Bicycle Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 01

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC) and Option Care Health (OPCH)

TIPRANKS
·
May 01

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
Apr 30

Bicycle Therapeutics Q1 FY26 net loss holds at USD 60.8 million; revenue drops to USD 0.9 million

Reuters
·
Apr 30

Bicycle Therapeutics Q1 Pretax Profit USD -60.653 Million

THOMSON REUTERS
·
Apr 30

Bicycle Therapeutics Q1 Operating Expenses USD 66.369 Million

THOMSON REUTERS
·
Apr 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

Bicycle Therapeutics PLC expected to post a loss of 62 cents a share - Earnings Preview

Reuters
·
Apr 27

Bicycle Therapeutics presents interim Duravelo-2 BT8009 plus Keytruda data at ASCO 2026

Reuters
·
Apr 21

Bicycle Therapeutics publishes investor presentation on Bicycle molecule platform and oncology pipeline

Reuters
·
Apr 20

Bicycle Therapeutics doses first patient in Phase 2 pancreatic cancer trial for nuzefatide pevedotin

Reuters
·
Apr 20

European Equities Traded in the US as ADRs Rise in Tuesday Trading

MT Newswires Live
·
Apr 14

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

Bicycle Therapeutics Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Apr 08

Bicycle Therapeutics COO Jennifer Scott Perry disposes of shares worth $6,803

Reuters
·
Apr 07